Referencias:

• Levin, V.A., Sheline, G.E., Gutin, P.H., Neoplasms of the central nervous system (1989) Cancer: Principles in Practice of Oncology, 3rd Edition, pp. 1557-1611. , De Vita, V.T., Hellman, S., Rosenberg, S.A. (Eds.). J.B. Lippincott Co.: Philadelphia
• Mahaley, M.S., Mettlin, C., Natarajan, N., National survey of patterns of care for brain tumor patients (1989) J Neurosurg, 71, pp. 826-836
• Jelsma, R., Bucy, P.C., Glioblastoma multiforme, its treatment and some factors affecting survival (1969) Arch Neurol, 20, pp. 161-171
• Edward, M.S., Levin, V.A., Wilson, C.B., Brain tumor chemotherapy: An evaluation of agents in current use for phase II and III trials (1980) Cancer Treat Rep, 64, pp. 1179-1205
• Walker, M.D., Green, S.B., Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery (1980) New Engl J Med, 303, pp. 1323-1329
• Hildebrand, J., Radiotherapy and chemotherapy of malignant brain gliomas (1986) Drugs Exp Clin Res, 12, pp. 167-175
• Kelly, P.J., Alker Jr., G.J., A stereotactic approach to deep seated SNC neoplasms using the carbon dioxide laser (1981) Surg Neurol, 15, pp. 331-334
• Ransohoff, J., Lieberman, A., Surgical therapy of primary malignant brain tumors (1978) Clin Neurosurg, 25, pp. 403-411
• Wharen, R.E., Anderson, R.E., Laws, E.R., Quantitation of hematoporphyrin derivate in human gliomas, experimental central nervous system tumors and normal tissue (1983) Neurosurgery, 12, pp. 446-450
• Gutin, H., Prados, M.D., Phillips, T.L., External irradiation followed by interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas. NCOG study 6G-82-2 (1991) Int J Radiat Oncol Biol Phys, 21, pp. 601-606
• Loeffler, J.S., Alexander, E., Shea, W.M., Radiosurgery as part of the initial management of patients with malignant gliomas (1992) J Clin Oncol, 10, pp. 1379-1385
• Hernandez, J.C., Maruyama, Y., Yaes, R., Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors (1990) J Neuro-Oncol, 9, pp. 41-45
• Shapiro, J.R., Pu, P.Y., Mohamed, A.N., Regional heterogeneity in high grade gliomas (1984) Proc Amer Assoc Cancer Res, 25, p. 375
• Shapiro, W.R., Shapiro, J.R., Principles of brain tumor chemotherapy (1986) Semin Oncol, 13 (1), pp. 56-59
• MacDonald, D., Cascino, T.L., Schold, C.S., Cairncross, J.G., Response criteria for phase II studies of supratentorial malignant gliomas (1990) J Clin Oncol, 8, pp. 1227-1280
• Zeltzer, P.M., Friedman, H.S., Norris, D.G., Criteria and definition of response and relapse in children with brain tumors (1985) Cancer, 56, pp. 1824-1826
• Cairncross, J.G., MacDonald, D.R., Successful chemotherapy for recurrent malignant oligodendroglioma (1988) Ann Neural, 23, pp. 360-364
• Stewart, D.J., The role of chemotherapy in the treatment of gliomas in adults (1989) Cancer Treat Rev, 16, pp. 129-160
• Rodriguez, L.A., Levin, V.A., Does chemotherapy benefit the patient with a central nervous system glioma? (1987) Oncology, 1, pp. 29-36
• Georges, P., Przedbordki, S., Brotchi, J., Effect of HeCNU in malignant supratentorial gliomas: A phase II study (1988) J Neuro-Oncol, 6, pp. 211-219
• Bleehen, N.M., Freedman, L.S., Stenning, S.P., A randomised study of CCNU with and without benzonidazole in the treatment of recurrent grade III-IV astrocytoma (1989) Int J Radiat Oncol Biol Phys, 16, pp. 1077-1081
• Fine, H.A., Dear, K.B.G., Loeffler, J.S., Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults (1993) Cancer, 71, pp. 2585-2597
• Meulemans, A., Giroux, B., Hannoun, P., Permeability of two nitrosoureas carmustine and fotemustine in rat cortex (1989) Chemotherapy, 35, pp. 313-319
• Meulemans, A., Giroux, B., Hannoun, P., Comparative diffusion study of two nitrosoureas: Carmustine and fotemustine in normal rat brain, human and rat brain biopsies (1991) Chemotherapy, 37, pp. 86-92
• Jacrot, M., Giroux, B., Deloffre, P., Activity of the nitrosourea fotemustine against a human glioma xenograft in the nude mice (1989) Proc 5th Eur Conf Clin Oncol, , Abst 492
• Frenay, M., Giroux, B., Khoury, S., Phase II study of fotemustine in recurrent supratentorial malignant gliomas (1991) Eur J Cancer, 27, pp. 852-856
• Antico, J., Pasccon, G., Turjansky, L., Phase II study of fotemustine in gliomas. Preliminary report (1995) Proc Amer Soc Clin Oncol, 14, p. 151
• Trandafir, L., Da Costa, L., Borel, C., Fotemustine and oral procarbazine combination regimen in the treatment of recurrent gliomas (1995) Proc Amer Soc Clin Oncol, 14, p. 159
• Biron, P., Roux, N., Chauvin, N., Phase I-II trial of high dose fotemustine followed by autologous bone marrow transfusion in high grade gliomas (1991) Eur J Cancer, 12, pp. S191
• Frenay, M., Giroux, B., Khoury, S., Three modalities of chemotherapy with fotemustine in supratentorial malignant gliomas (1991) Eur J Cancer, 27, pp. 852-856
• Bourdin, S., Juin, P., Hery, M., Combination of fotemustine (S 10036) and radiotherapy in malignant gliomas: Report of the French Multicentric study (1989) Proc Amer Assoc Cancer Res, , Abst 5698
• Greenberg, H.S., Ensminger, W.D., Chandler, W.F., Intraarterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system (1984) J Neurosurg, 61, pp. 423-429

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------